SCHEMBL30148352

SCHEMBL30148352

CC(C)(O)c1cccc(Cl)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 6/20 0.39
PDK2 Q15119 6/20 0.39
PDK3 Q15120 6/20 0.39
PDK4 Q16654 6/20 0.39
PGR P06401 1/20 0.38
CA2 P00918 1/20 0.37
RXRA P19793 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
HSD11B1 P28845 1/20 0.35
NOTUM Q6P988 1/20 0.34
TNKS O95271 2/20 0.33
PARP1 P09874 2/20 0.33
TNKS2 Q9H2K2 2/20 0.33
CFD P00746 1/20 0.33
NR3C1 P04150 1/20 0.33
NR3C2 P08235 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10896805 0.84 KCNN4 (0.37) PDK1PDK2PDK3PDK4PGR
SCHEMBL8225791 0.83 CA2 (0.44) PDK1PDK2PDK3PDK4CA2
SCHEMBL2447455 0.81 PDK1 (0.35) PDK1PDK2PDK3PDK4CA2
SCHEMBL12373152 0.81 P2RX7 (0.35) PDK1PDK2PDK3PDK4CA2
SCHEMBL16579358 0.79 KCNN4 (0.39) PDK1PDK2PDK3PDK4CA2
SCHEMBL11837116 0.79 P2RX7 (0.38) PDK1PDK2PDK3PDK4CA2
SCHEMBL20079605 0.79 CFD (0.33) PDK1PDK2PDK3PDK4CA2
SCHEMBL11792315 0.78 TSHR (0.44) PDK1PDK2PDK3PDK4PGR
SCHEMBL10748080 0.78 TSHR (0.39) NOTUMCFDGAATDP1
SCHEMBL30530487 0.78 KCNN4 (0.45) PDK1PDK2PDK3PDK4PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266427-A1 4-(ARYL-METHYL-AMINO)-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed